Announcements

Drug deals

Bashir Mamdani

DOI: 10.20529/IJME.2005.032


Abstract

While justifying high prices by the high risk of failure of new drugs, the industry consistently reports higher profits than any other industry, 17% vs 3.1% for all the other industries on the Fortune 500 list – hardly a sign of high risk. The high profits reflect the exorbitant prices, particularly in the US, where, unlike most countries, there is no governmental mechanism to regulate drug prices.

Full Text

HTML PDF

Keywords

N/A

Refbacks

There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US